Cal-Maine to 'vigorously' fight jury decision that it conspired to inflate egg prices
Cal-Maine Foods Inc. (CALM) said Wednesday that a jury found the egg producer, along with other defendants, were liable for an alleged conspiracy to inflate egg product prices. The damages part of the trial is slated to take place on Nov. 28 and Nov. 29. Cal-Maine's stock slumped 1.7% in morning trading, while the S&P 500 gained 0.2%. "While we are disappointed with the overall decision, we prevailed on a number of issues that we believe are important and should ultimately define this case," Cal-Maine said in a statement. For example, it was alleged that the conspiracy ran from 1998 to 2008 with damages extended to 2012, but the jury determined that the alleged damages would be limited to 2004 to 2008, and also rejected other portions of the plaintiffs' case. "Cal-Maine will vigorously contest plaintiffs' presentation of purported damages and will continue to assess the decision and options for appeal," the company said.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-22-23 1004ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks